Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany

OBJECTIVES: We examined rheumatologists’ motivation for prescribing biosimilars, assessed their treatment preferences in relation to prescribing behavior and explored patient attitudes to biosimilars. METHODS: Data were taken from the Adelphi Real World Biosimilars Programme, a real-world, cross-sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Waller, John, Sullivan, Emma, Piercy, James, Black, Christopher M, Kachroo, Sumesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356924/
https://www.ncbi.nlm.nih.gov/pubmed/28331299
http://dx.doi.org/10.2147/PPA.S129333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356924/
https://www.ncbi.nlm.nih.gov/pubmed/28331299
http://dx.doi.org/10.2147/PPA.S129333

Ejemplares similares